4.8 Article

Systolic Heart Failure

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 362, Issue 3, Pages 228-238

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp0909392

Keywords

-

Funding

  1. Bristol-Myers Squibb
  2. Novartis
  3. Amgen
  4. AstraZeneca
  5. F. Hoffmann-La Roche
  6. Pfizer
  7. GlaxoSmithKline
  8. Scios

Ask authors/readers for more resources

A 74-year-old man with a history of hypertension and myocardial infarction that occurred 5 years previously presents with breathlessness on exertion. His current medications include a statin and aspirin. On examination, his pulse is 76 beats per minute and regular, and his blood pressure is 121/74 mm Hg. There is jugular venous distention, lateral displacement of the apex beat, and edema in his lower limbs. The lung examination is normal. An echocardiogram shows left ventricular dilatation, globally reduced contractility, and an ejection fraction of 33%. How should his case be managed?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available